AssetMark’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding GMAB
AssetMark's GMAB Position: Q3 2026 in Review
AssetMark increased its Genmab (GMAB) stake by 5.1% in Q3 2026, buying an estimated $382K and bringing the position to 250,893 shares worth $8.95M. The position accounts for 0.02% of the portfolio, ranked #594.
AssetMark first reported a position in GMAB in Q3 2019 and has held it in 29 quarters since. 258 funds tracked by Wall St. Rank hold GMAB as of Q3 2026.
- AssetMark held 250,893 shares of Genmab worth $8.95M as of Q3 2026.
- AssetMark bought 12,090 Genmab shares in Q3 2026, an estimated $382K.
- Genmab made up 0.02% of AssetMark's portfolio in Q3 2026, its #594 holding.
- AssetMark first reported a position in Genmab in Q3 2019 and has held it in 29 quarters since.
- 258 funds tracked by Wall St. Rank held Genmab as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.